KS is the most common cause of acquired heart disease now. The clinical picture of patient with KD is Conjuctivitis, strawberry tongue, skin rash, induration and desquamation KD was first described in 1967 by Dr. Kawasaki in japan
From previous reports: Increased prevalence of Atopic Dermatitis has been noted in KD And also, peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels have been found in KD
We then analyzed the levels of eosinophil related Th2 cytokines and mediators , and found that the levels of IL-4, IL-5, eotaxin, ECP and CRP were significantly higher in KD patients before IVIG treatment when compared to the controls.
Further, we analyzed the relationship between the changes of eosinophil, Th2 cytokines and ECP We found that the change of eosinophil is positively correlated with the changes of IL-5 levels but not the ECP levels. This result suggests therefore that the increase of eosinophil may be related to the upregulated IL-5 levels.
We next examined the levels of eosinophil and IL-5 in patients with or without CAL after IVIG treatment, and interestingly, we found that both the eosinpphil percentage abd the levels of plasma IL-5 were significantly higher in KD patients without CAL than those found in patients with CAL. These results suggest, therefore, that eosinophil and related cytokines may be associated with protection of CAL formation
Kuo et al. Acta Pediatr Twiwan . 2006;47(suppl):7-17. 非特異性臨床特徵
Non-Langerhans cell histiocytosis in KD Figure 3:The dermis reveals infiltration of histiocytes and multinucleate giant cells mixed with some lymphocytes (hematoxylin and eosin stain, 100X). Touton giant cells are also present (upper right corner, 400X). Figure 4: On immunohistochemical study, the histiocytes are diffuse positive for CD68 (A), but negative for S100 (B) and CD1a (C).
Poor response to repeat IVIG dosage and response to MP pulse Non-LCH in KD IVIG IVIG MP
Oct 2007, Tokyo, Japan.
Fever >= 5 days
< 4 diagnostic criteria, with CAL
About 15%
Nippon Rinsho. 2008 ;66:321-5.
<3m/o or > 6y/o
<6m/o vs. > 6m/o
(35% vs.12%, p=0.025)
Pediatr Infect Dis J 2006; 25:241-4.
Incomplete or atypical KD
ESR>40 or CRP >30
輔助性的診斷 指標 ( ≧3) :
白蛋白指數 (< 3)
尿液檢查 (WBC>10/HPF)
肝功能指數異常
白血球數量 (>15000)
血色素 (anemia by age)
血小板數目 (45 萬 ,7 days)
排除其他類似之臨床疾患 。
Circulation 2004;110;2747-2771. Incomplete or atypical KD
Delay diagnosis of KD Pediatrics 2005;115;428-433. >10 days High risk of CAL J Chin Med Assoc. 2007;70:374-9. ( 北榮 , N=14/78)
Pediatrics 2007;120;e1434-e1440. Delayed Diagnosis of Kawasaki Disease: What Are the Risk Factors?
Feb 2008, Seoul, Korea
History of IVIG in KD
1981: Imback: IVIG in ITP ( Lancet )
1983: Furusho: IVIG in 40 Japanese patients with KD ( Lancet )
1986: US Multicenter KD Study Group: 168 KD patients, 400mg/kg x 4 d reduces CAA from 20% to 3-5 % ( NEJM )
1991: US Multicenter KD Study Group: 549 US patients, single infusion of 2 g/kg superiors to 400mg/kg x 4d in reducing fever and inflammatory markers ( NEJM )
High dose IVIG (2gm/kg)
Aspirin (80-100 mg/kg) in acute stage
Aspirin (3-5 mg/kg) after fever subside
Normal ESR, Plt and 2D echo
Aspirin: (should receive an annual influenza vaccine)
北美地區 (80~100mg/kg/day) Nelson textbook
Circulation 1993; 87:1776-80.
日本地區中等劑量 (30~50mg/kg/day)
Prog Clin Biol Res 1987; 250:401-13.
Hsieh KS et al. 於 1993~2003 統計 162 位 KD
Pediatrics 2004; 114;689-93.
Treatment Q2: standard Tx for KD
Day 4
Early IVIG treatment for KD: the nationwide surveys in Japan.
J Pediatr 2005;146:149-50.
Day 5
15,940 KD patients in Japan
Pediatr Infect Dis J. 2008;27:155-160.
Treatment- IVIG timing
Infection vs. KD Pediatrics 2005;116;e760-e766. Diagnosis of KD start IVIG Tx stop antibiotics ?
約 7.8%~38%
Pediatr Cardiol. 2003; Pediatr Infect Dis J. 1998
Pediatr . 2008 Jul;153(1):117-21.
Our hospital: 10.8% (30/278)
3-4% non-response to 2nd dose IVIG
4/278 (1.4 % in our hospital)
20% in Japan
Nippon Rinsho . 2008;66:332-7.
Recurrent KD: 6.89 per 1000/years
Acta Paediatr. 2001;90:40-4 .
2/278 (0.72% in our hospital)
Initial IVIG treatment failure
Sep 2008, KL, Malaysia
30/278, 10.8% IVIG responsive and resistant KD patients from 1999-2007 in CGMH-KS 17.3% 7.3% 7.8% 17.5% 15% 9.1% 13.6% 6.9% 5.12%
J Pediatr 2008;153:117-21. IVIG responsive and resistant KD patients in San Diego County (1998-2006)
J Pediatr 2008;153:117-21 Comparison between IVIG responsive and resistant KD patients
Eur J Pediatr (2007) 166:131–137 Risk factors to predict IVIG resistance in KD
The median (range) of the interval between the first attack of KD and the second attack was 145 (9-1891) days.
85% (80/94) of the second attack occurred within 2 years following the first episode
coronary artery aneurysm in 7.3% (536/7305)
Kawasaki Disease in a Pediatric Intensive Care Unit: A Case-Control Study Pediatrics published online Sep 22, 2008;
J Pediatr 2008;153:365-8. Risk Factors for Nonresponse to Therapy in Kawasaki Disease
Methylpredinsolone pulse
Cyclosporin
Cyclophosphamide
Methotrexate
Scand J Rheumatol 2005;34:136-9.
Plasma exchange
Eur J Pediatr. 2004;163:263–264.
Pentoxifylline (inhibit TNF mRNA)
Eur J Pediatr. 1994;153:663–667.
Abciximab
Enbrel
Ulinastatin
trypsin inhibitor
Other Treatment
N Engl J Med 2007;356:663-75. MP pulse in KD
MP pulse in KD Wang CL et al. J Microbiol Immunol Infect. 2005. J Pediatr 2003;143:363-7
Sep 2008, Xiamen, China
May 2008, Honolulu, Hawaii
Kuo and Yang et al. Pediatr Allergy Immunol 2007;18:354–359. Univariate and multivariate analysis of KD patients between IVIG responsive and IVIG-resistant groups
Kuo and Yang et al. Pediatr Allergy Immunol 2007;18:354–359.
In press: Pediatr Allergy Immunol 2008
Eosinophil increase in acute KD and inverse correlation with IVIG resistant Kuo and Yang et al. Pediatr Allergy Immunol 2007;18:354–359.
In press: Pediatr Allergy Immunol 2008
Prognosis - role of eosinophil Kuo et al. Pediatr Allergy Immunol 2007 In press: Pediatr Allergy Immunol 2008
May different brands of IVIG affect the eosinophil counts in KD ? Kuo et al. Pediatr Allergy Immunol 2008;19:184-5.
Male gender
Recurrent KD
IVIG before day 4
IVIG after day 10
IVIG dose <1000 mg/kg
Hb<10 gm/dL
Neutrophil >75%
band form
Eosinophil
Albumin < 3 gm/dL
Predict of IVIG resistance
Immune Activation Genetic Susceptibility Vasculitis Coronary artery lesions (CD40L, Skewed Th1/Th2) ( CTLA4 polymorphism ) ( NO vs NOS ) Infections, Super-Ag Kawasaki Disease vs. IVIG
Gender limited cytotoxic T lymphocyte antigen-4 (CTLA-4) polymorphism with intravenous Immunoglobulin resistant in Kawasaki Disease 2008 FIMSA
CTLA4 +49 A allele was significantly associated with the IVIG resistance in females, but not males 2008 FIMSA P=0.01 P=0.7
2008 FIMSA
Thanks a lot for your attention and comment !!!
Increased prevalence of atopic dermatitis in KD.
Pediatr Infect Dis J . 1988.
Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acute KD.
Pediatr Infect Dis J . 2002.
Eosinophil and allergy in KD
Eosinophil increase in acute KD and inverse correlation with IVIG resistant Kuo and Yang et al. Pediatr Allergy Immunol 2007;18:354–359.
Levels of eosinophil-related Th2 cytokines and ECP were higher in KD Control: upper respiratory track infection, student t test. <0.001 2.98±0.23 10.9±1.71 ECP (pg/ml) <0.001 2.65±0.55 5.17±0.56 IL-5 (pg/ml) 0.004 74.52±7.45 116.7±12.5 Eotaxin (pg/ml) <0.001 5.96±0.54 12.07±1.36 IL-4 (pg/ml) P value Control (N=30) KD (N=95)
Changes of eosinophil-related Th2 cytokine and ECP after IVIG treatment
Changes of eosinophils positively correlated with IL-5 but not ECP Eosinophil vs. IL-5 Eosinophil vs. ECP
Mann-Whitney U test Eosinophils and IL-5 after IVIG treatment were significantly higher in KD without CAL
Untreated: 20-25% aneurysm formation
IVIG Tx: 3-10%
Predict factors
Delay Tx
Persistent fever
Low IgG
High IgA
Low Hb
Resistant to initial IVIG Tx
Hct<32.5, neutrophil >68%
Acta Paediatr 2002; 91:517-20.
Albumin<3
Persistent monocytosis
Kuo et al. J Microbiol Immunol Infect . 2007;40:395-400.
0 comments
Post a comment